BioCatch vs Unit21

BioCatch has a disclosed valuation of $1B, while Unit21's valuation is not publicly available, making a direct size comparison difficult. BioCatch employs 100-500 people.

BioCatch has raised more in total funding at $213M, compared to Unit21's $75M — a gap of $138M.

BioCatch holds the higher Awaira Score at 80/100, compared to Unit21's 60/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 20-point gap that reflects meaningful differences in scale or traction.

BioCatch was founded by Avi Turgeman in 2011. Unit21 was founded by Trisha Kothari in 2018. Visit each company's profile on Awaira for a full founder biography.

BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection. Unit21: Unit21 provides a fraud and risk operations platform that enables compliance and fraud teams at financial institutions and fintechs to build, test, and deploy transaction monitoring rules and machine learning models without requiring data science resources. The platform covers transaction fraud, account takeover, ACH and check fraud, and anti-money laundering (AML) case management in a unified workflow.\n\nThe company raised approximately 75 million USD and serves hundreds of financial services customers including neobanks, payment processors, crypto exchanges, and traditional banks looking to modernize legacy fraud operations with configurable, model-driven risk infrastructure. Unit21 no-code rule builder allows risk analysts to respond to new fraud patterns within hours rather than weeks.\n\nFinancial fraud losses in the United States exceed 10 billion USD annually and are growing as faster payment rails reduce the window for detection. Unit21 competes with legacy vendors like NICE Actimize and SAS as well as newer entrants including Sardine and Alloy, differentiating through its analyst-friendly interface and the speed with which risk teams can iterate on detection logic without engineering dependencies.

BioCatch was founded first in 2011, giving it 7 years of additional market experience. Unit21 was founded later in 2018. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.

Both BioCatch and Unit21 report similar employee counts of approximately 100-500. Team size is often a proxy for operational scale, though lean AI companies can punch well above their headcount.

Yes, BioCatch and Unit21 are direct competitors — both operate in the AI Security space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.